BioPlus Acquisition Corp Financials
BIOSWDelisted Stock | USD 0.14 0.00 0.00% |
BioPlus |
Understanding current and past BioPlus Acquisition Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioPlus Acquisition's financial statements are interrelated, with each one affecting the others. For example, an increase in BioPlus Acquisition's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in BioPlus Acquisition's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioPlus Acquisition Corp. Check BioPlus Acquisition's Beneish M Score to see the likelihood of BioPlus Acquisition's management manipulating its earnings.
BioPlus Acquisition Stock Summary
BioPlus Acquisition competes with BurTech Acquisition. BioPlus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York. Bioplus Acquisition operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
Business Address | 260 Madison Avenue, |
Sector | Capital Markets |
Industry | Financials |
Benchmark | Dow Jones Industrial |
Website | bioplusspac.com |
Phone | 212 287 4092 |
Currency | USD - US Dollar |
BioPlus Acquisition Key Financial Ratios
BioPlus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioPlus Acquisition's current stock value. Our valuation model uses many indicators to compare BioPlus Acquisition value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioPlus Acquisition competition to find correlations between indicators driving BioPlus Acquisition's intrinsic value. More Info.BioPlus Acquisition Corp is rated second in number of shares shorted category among its peers. It is rated third in ebitda category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value BioPlus Acquisition by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.BioPlus Acquisition Market Pulse
Quote | 0.14 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 0.14 |
Low | 0.14 |
High | 0.14 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as BioPlus Acquisition is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of BioPlus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if BioPlus Acquisition's financials are consistent with your investment objective using the following steps:- Review BioPlus Acquisition's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand BioPlus Acquisition's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare BioPlus Acquisition's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if BioPlus Acquisition's stock is overvalued or undervalued.
BioPlus Acquisition November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioPlus Acquisition help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioPlus Acquisition Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioPlus Acquisition Corp based on widely used predictive technical indicators. In general, we focus on analyzing BioPlus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioPlus Acquisition's daily price indicators and compare them against related drivers.
Downside Deviation | 13.32 | |||
Information Ratio | 0.1172 | |||
Maximum Drawdown | 64.6 | |||
Value At Risk | (16.82) | |||
Potential Upside | 20.0 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |